- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Study affirms safety of adenosine test
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
Study affirms safety of adenosine test
By: James Brice
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
A study of adenosine safety conducted by researchers at St. Marien Hospital in Bonn, Germany, may put those concerns to rest. Dr. Karol Miszlaski-Jamka did record minor side effects, such as facial flushing and mild shortness of breath, in 81% of the 645 patients who underwent adenosine-stress contrast MR. But major side effects were limited, including 23 cases of transient high-degree atrioventricular block that resolved spontaneously, one case of severely increased blood pressure, and two instances of claustrophobia.
Study affirms safety . . .
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
